Trial Profile
IL-2 neuropsychiatric symptoms: mechanism and prevention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression
- Focus Therapeutic Use
- 07 May 2008 New trial record.